Revolutionising Liver Health, One Cell at a Time

Pioneering the next generation of liver research and therapy with our chemically expanded human hepatocytes (cHeps)

NEXT GEN LIVER RESEARCH

We deliver solutions to liver problems.

At De-Liver, we’re pioneering the next generation of liver research and therapy with our chemically expanded human hepatocytes (cHeps), a scalable, cost-effective, and fully functional alternative to traditional hepatocyte models.

Our cutting-edge cHeps technology empowers drug discovery, cell-based therapies, and liver disease research with unmatched consistency, availability, and clinical potential.

Cost-Effective

Significantly reduce costs without compromising quality, ideal for high-throughput drug screening and translational research.

Scalable Supply

From bench to bedside, our cHeps offer a consistent and abundant source of hepatocytes, ready for your evolving needs.

Quality-Controlled

Standardised production and rigorous testing ensure batch-to-batch consistency and scientific reliability.

Transplantable

cHeps exhibit authentic hepatocyte functionality and are suitable for transplantation and regenerative medicine applications.

Genetically Modifiable

Easily tailor cHeps for disease modeling, gene therapy research, and custom applications.

RESEARCH

Help Shape the Future of Liver Research

De-Liver is the product of early-stage, translational research developed at the prestigious University of Edinburgh, supported by funding from Innovate UK.

Your insights are crucial to guide its next steps.

We’re actively seeking feedback from researchers, clinicians, biotech innovators, and industry leaders like you.

Download Our Research Pack for detailed specifications, use cases, and validation data.

APPLICATIONS

Powering Innovation Across Research and Medicine

Our cHeps technology is purpose-built to meet the evolving demands of the life sciences. From early-stage discovery to advanced clinical applications.

Pharma Company

Contract Research

Academic Labs

Biotech & Startups

Clinical Applications

de-Liver Team

Discover Our Project Team

My Linh Huynh

Entrepreneurial lead

Keisuke Kaji

Principal Scientific Adviser

Barbara Blaney

Technology Transfer Officer

Contact Us

Complete the form below and one of our team will be in touch soon. 

Get in touch

Let’s collaborate on transforming liver health.

Our mission is bold: to deliver scalable, affordable, and clinically relevant human hepatocytes to accelerate liver research, transform therapeutic development, and enable the next generation of regenerative medicine.

A University of Edinburgh Commercialisation project, supported by Innovate UK.